Home > Insider Trading > Filing (0001628280-24-049800)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	Services-Offices & Clinics Of Doctors Of Medicine (8011)	043705970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2037711	Carlos Nueno	C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577	President, International	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-11-29	1,056	$0.00	1,056	No	4	M	Direct
Common Stock	Acquisiton	2024-11-29	1,123	$0.00	2,179	No	4	M	Direct
Common Stock	Acquisiton	2024-11-29	3,100	$0.00	5,279	No	4	M	Direct
Common Stock	Disposition	2024-12-02	2,389	$11.93	2,890	No	4	S	Direct
Common Stock	Disposition	2024-12-03	2,890	$11.23	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Units	Disposition	2024-11-29	1,056	$0.00	1,056	$0.00
Common Stock	Restricted Stock Units	Disposition	2024-11-29	1,123	$0.00	1,123	$0.00
Common Stock	Restricted Stock Units	Disposition	2024-11-29	3,100	$0.00	3,100	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,285	No	4	M	Direct
1,123	No	4	M	Direct
15,502	No	4	M	Direct

Footnotes

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 6, 2023.
On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 1, 2022, the reporting person was granted 13,475 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.